The millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering customers a compounded version of semaglutide, the active ...

The future of weight loss is looking more varied by the second. This week, scientists have reported the preliminary findings of a small trial testing out a ...

Image: Hollie Adams (Reuters)It’s not only food CEOs who need to worry about their bottom lines thanks to in-demand weight loss drugs like Ozempic. Big ...